title: HCV and hypogammaglobulinemia.
authors.forename: F J
authors.initials: FJ
authors.lastname: Sierra
authors.forename: A
authors.initials: A
authors.lastname: Gil-Aguado
authors.forename: J M
authors.initials: JM
authors.lastname: Echevarria
authors.forename: P
authors.initials: P
authors.lastname: León
authors.forename: J C
authors.initials: JC
authors.lastname: Martin
authors.forename: P
authors.initials: P
authors.lastname: Lavilla
authors.forename: M C
authors.initials: MC
authors.lastname: Garcia Rodriguez
authors.forename: G
authors.initials: G
authors.lastname: Fontan
mesh_terms: D000328:Adult; D000361:Agammaglobulinemia / Q000517:prevention & control* / Q000821:virology*; D005260:Female; D016174:Hepacivirus / Q000302:isolation & purification*; D006526:Hepatitis C / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects* / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D015995:Prevalence
chemical_list: D016756:Immunoglobulins, Intravenous; D007372:Interferons